IP Library Granted Patent US 11,590,259
Granted Patent B2
US 11,590,259 · App. 17/348,468 · Granted Feb 28, 2023

Composition and kits for pseudoplastic microgel matrices

Inventors: Joseph Charles Salamone (San Antonio, TX); Ann Beal Salamone (San Antonio, TX); Katelyn Elizabeth Reilly (San Antonio, TX); Laura Jean Suggs (Austin, TX); Eunna Chung (Seoul, KR); Kelly Xiaoyu-Chen Leung (San Antonio, TX)
Assignee: ROCHAL TECHNOLOGIES LLC
A61L27/22A61L27/18A61L27/225A61L27/227A61L27/24A61L27/26A61L27/3604A61L27/3633A61L27/38A61L27/3834A61L27/52A61L27/54A61L2300/406A61L2400/06
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,590,259
App. No.
17/348,468
Granted
Feb 28, 2023
Kind
B2
Abstract

This invention relates generally to water-insoluble but water-swellable and deformable crosslinked PEGylated microgel particles of proteins and protein-based macromolecules that are pseudoplastic (shear thinning) and flow in aqueous media under shear and which can be injected or made to flow, wherein said microgel particles can reform as a cluster of microgel particles when shearing forces are removed. The microgel particles function as a matrix to support cell growth, viability, and proliferation.

Claims (30)

1. A composition comprising:

a plurality of water-insoluble, hydrogel microparticles comprising PEGylated gel microparticles comprising a protein or protein-based biological macromolecule crosslinked with a PEGylating agent;

where said protein or protein-based biological macromolecule is selected from the group consisting of collagen, gelatin, and combinations thereof;

wherein the PEGylating agent is α-succinimidyloxyglutaryl-ω-succinimidyloxyglutaryloxypolyoxyethylene (SG-PEG-SG);

wherein the plurality of water-insoluble, hydrogel microparticles are hydrated by an aqueous medium;

wherein the plurality of water-insoluble, hydrogel microparticles are obtained by lyophilizing and then grinding monolithic hydrogels;

wherein the composition includes clusters of the microparticles in the absence of shear, and the composition decreases in viscosity and exhibits viscoelastic solid properties with applied shear; and

wherein a molar ratio of PEGylating, agent to protein and/or protein-based biological macromolecule is from 10:1 to 50:1.

2. A composition comprising:

a plurality of water-insoluble, hydrogel microparticles comprising PEGylated gel microparticles comprising a protein or protein-based biological macromolecule crosslinked with a PEGylating agent that is difunctional to poly-functional;

where said protein or protein-based biological macromolecule is selected from the group consisting of gelatin, collagen, and combinations thereof;

wherein the plurality of water-insoluble, hydrogel microparticles are hydrated by an aqueous medium;

wherein the plurality of water-insoluble, hydrogel microparticles are obtained by lyophilizing and then grinding monolithic hydrogels;

wherein the composition includes clusters of the microparticles in the absence of shear, and the composition decreases in viscosity and exhibits viscoelastic solid and pseudoplastic properties with applied shear; and

wherein a molar ratio of PEGylating agent to protein and/or protein-based biological macromolecule is from 10:1 to 50:1.

3. The composition according to claim 2 , wherein said composition has viscoelastic solid properties, a storage modulus greater than loss modulus, and a loss tangent value less than 1.

4. The composition according to claim 2 , wherein storage modulus values of the composition, the plurality of water-insoluble; hydrogel microparticles, which are hydrated, or both, are between 10 Pa to 250,000 Pa and said loss modulus values are between 5 Pa to 100,000 Pa.

5. The composition according to claim 2 , wherein the composition is in a form selected from the group consisting of solutions, suspensions, creams, lotions, gels, pastes, emulsions, balms, sprays, foams, aerosols, and other formulations thereof.

6. The composition of claim 2 , wherein the pseudoplastic properties are independent of the aqueous medium used to hydrate the plurality of water-insoluble, hydrogel microparticles.

7. The composition of claim 2 , wherein the plurality of water-insoluble, hydrogel microparticles are irregularly shaped and not spherical or elliptical.

8. The composition according to claim 2 , wherein the plurality of water-insoluble, microparticles are in the form of a dry powder.

9. The composition according to claim 2 , wherein said PEGylating agent is selected from α-succinimidyloxyglutaryl-ω-succinimidyloxyglutaryloxypolyoxyethylene (SG-PEG-SG), pentaerythritol tetra(succinimidyloxyglutaryl)polyoxyethylene, 4-aim succinimidyloxyglutaryl)polyoxyethylene, polyethylene glycol) di(proprionaldehyde), and combinations thereof.

10. The composition according to claim 2 , further comprising an antibacterial agent, an antifungal agent, monoacyl glycerol, monoalkyl glycol, poly(hexamethylene biguanide) and its salts, and combinations thereof.

11. The composition according to claim 2 , further comprising water-soluble polymers at a concentration of from 0.01 weight % to 25 weight %.

12. The composition according to claim 11 , wherein the water-soluble polymers are selected from gelatin, albumin, pullulan, poly(L-lysine), and antimicrobial peptides.

13. The composition according to claim 2 , further comprising a biological component.

14. The composition according to claim 13 , wherein the biological component is selected from cells; micronized tissue and micronized decellularized tissue; synthetic or naturally derived extracellular matrix components; glycosaminoglycans, fibrin, laminin, fibronectin; hydroxyapatite; polysaccharides; poly(amino acids; and combinations thereof.

15. The composition according to claim 14 , wherein the synthetic or naturally derived extracellular matrix components comprise collagen, glycosaminoglycans, fibrin, laminin or fibronectin.

16. The composition according to claim 2 , further comprising at least one biologically active agent.

17. The composition according to claim 16 , wherein the at least one biologically active agent is selected from antimicrobial agents, analgesic agents, anti-inflammatory agents, wound healing agents, Si-RNA, and combinations thereof.

Assignments (5)
SECURITY INTEREST Recorded Apr 18, 2024
From: ROCHAL TECHNOLOGIES, LLC
To: CRG SERVICING LLC
Reel/Frame 067154/0698 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 29, 2022
From: ROCHAL INDUSTRIES, LLC
To: SANARA MEDTECH INC.
Reel/Frame 060359/0001 →
NUNC PRO TUNC ASSIGNMENT Recorded Jun 29, 2022
From: SANARA MEDTECH INC.
To: ROCHAL TECHNOLOGIES LLC
Reel/Frame 060359/0037 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2021
From: SALAMONE, JOSEPH CHARLES; SALAMONE, ANN BEAL; REILLY, KATELYN ELIZABETH; SUGGS, LAURA JEAN; CHUNG, EUNNA; LEUNG, KELLY XIAOYU-CHEN
To: ROCHAL INDUSTRIES, LLP
Reel/Frame 056552/0844 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2021
From: ROCHAL INDUSTRIES, LLP
To: ROCHAL INDUSTRIES, LLC
Reel/Frame 056552/0859 →
Continuity (2)
Division 14689625 · Apr 17, 2015
Related Publication 20210308323A1 · Oct 7, 2021